Tag Archives: healthcare

Patient Assistance Programs: Are They Still Relevant?

One of the key reputational assets of Big Pharma is the patient assistance program [PAP], which provides patented innovative medicines to needy patients for free or at a nominal charge – it’s the industry’s own branded version of the social safety net. But a shifting landscape of government fiscal pressures, economic decline and the erratic […]
Posted in healthcare, Regulatory | Also tagged , , , , | Leave a comment

PCORI, Priorities, and Politics

William Looney looks at the three P’s of effectiveness  research:  PCORI, Priorities, and Politics If you ever wanted to know what health economists might do with a billion dollars, the Obama Administration’s  Patient-Centered Outcomes Research Institute [PCORI] is about to tell all:  not right down to the penny, but good enough.  The congressionally funded – […]
Posted in healthcare, Regulatory | Also tagged , , , | Leave a comment

JP Morgan Healthcare Conference Marked by Uncertainty

2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of […]
Posted in Guest Blog, healthcare, R&D, Strategy | Also tagged , , , | 2 Comments

The Seven-Billion Society: What's In It For Pharma?

On Monday, the world’s population hit the 7 billion mark, repeating a pattern of largely unrestrained growth that has endured for the last century: the world is now adding roughly one billion people every 12 years. The UN Population Fund (UNPF) estimates that, barring some unforeseen demographic or environmental/development shifts, the figure will reach just […]
Posted in Global, healthcare, Op-Ed | Also tagged , , , | 1 Comment

So, Where Are We with ACOs?

Tom Norton gets to grips with what an Accountable Care Organization is … and what it is not. Sixteen months into the new Healthcare Reform law, many continue to wonder about the status one of the most confused aspects of the new HCR — the elusive Accountable Care Organization, or ACO. And why are ACOs […]
Posted in Guest Blog, Regulatory | Also tagged , , , , | 2 Comments
  • Categories

  • Meta